A Phase 2a Study of BIIB074 in the Treatment of Erythromelalgia

Summary

The primary objective of the study is to investigate the efficacy of repeat oral dosing of BIIB074 on paroxysmal pain in participants with Primary Inherited Erythromelalgia (EM). The secondary objective of the study is to investigate the efficacy of repeat oral dosing of BIIB074 on varying additional aspects of pain in participants with EM; and to investigate the safety and tolerability of repeat oral dosing of BIIB074 in participants with EM.

Timeline

Start

2016-09-09

Primary completion

2016-12-27

Completion

2017-01-05

Drugs

Indications